Chapter 10 - Musculoskeletal and joint diseases

Folder Chapter 10 - Musculoskeletal and joint diseases

Documents

Toggle Title Date
pdf Glucosamine Policy Statement Feb 2015 ( pdf, 370 KB ) (2346 downloads) Popular
pdf Osteoporosis; Prevention in IBD patients Jan 2015 ( pdf, 150 KB ) (4674 downloads) Popular
pdf Gout; Treatment and Management July 2018 ( pdf, 602 KB ) (10883 downloads) Popular
default Sodium Hyaluronate IA injections Policy Statement Feb 2015 ( pdf, 327 KB ) (2985 downloads) Popular
pdf Methotrexate self injection advice patient information Nov 2018 ( pdf, 273 KB ) (5995 downloads) Popular
pdf Biologics pathway for Axial Spondyloarthritis May 2018 ( pdf, 266 KB ) (3088 downloads) Popular
pdf Rheumatoid arthritis pathway for PbR excluded drugs ( pdf, 600 KB ) (2493 downloads) Popular
pdf Acute and chronic combined Pain guidelines August 2019 ( pdf, 610 KB ) (1326 downloads) Popular
pdf Osteoporosis - primary and secondary prevention guidelines ( pdf, 489 KB ) (6135 downloads) Popular
pdf Upadacitinib for treating severe rheumatiod arthritis (NICE TA665) MSEMOC position statement (Feb21) ( pdf, 195 KB ) (464 downloads) Popular
pdf Filgotinib for treating moderate to severe rheumatoid arthritis (NICE TA676) MSEMOC position statement (May21) ( pdf, 174 KB ) (291 downloads) Popular
pdf Anti TNFs and abatacept for moderate rheumatoid arthritis(NICE TA715) MSEMOC position statement Oct 2021 ( pdf, 155 KB ) (216 downloads) Popular
pdf Guselkumab for psoriatic arthritis (NICE TA711) position statement MSEMOC Oct 2021 ( pdf, 156 KB ) (207 downloads) Popular
pdf Secukinumab for non radiographic axial spondyloarthritis (NICE TA719) MSEMOC position statement Oct 2021 ( pdf, 172 KB ) (208 downloads) Popular
pdf Severe Psoriatic Arthritis treatment pathway MSEMOC Oct 2021 ( pdf, 234 KB ) (111 downloads) Popular